The Filings Report

MetLife, Inc.

METNYSECIK 1099219Financial / Insurance - Lifefiscal year ends December73 quarters since 2008

Revenue, Q2 FY2026
$19.2B
+10.5% on Q2 FY2025
Net income
$736M
+1.0% on Q2 FY2025
Free cash flow
—
no year-earlier figure
Diluted EPS
$1.09
+5.8% on Q2 FY2025
Revenue, TTM
$79.4B
trailing four quarters
Net margin, TTM
4.6%
net income $3.6B
Free cash flow, TTM
—
Cash and equivalents
$19.3B
long-term debt —, Jun 30, 2026
Shares, 12-month change
−4.4%
635M shares, Jun 30, 2026
Buybacks, TTM
$2.4B
3.8% of market value
Dividends, TTM
$1.5B
2.4% of market value
Market value
$63.6B
at the close, buybacks

Latest quarter Q2 FY2026, filed August 6, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q2 FY2026, the quarter ended June 30, 2026, MetLife, Inc. reported revenue of $19.2B, +10.5% on Q2 FY2025, and net income of $736M (+1.0%). Operating margin was 8.4%. Diluted earnings per share were $1.09.

The last 16 quarters

Q3 FY2022 to Q2 FY2026, through the filing of August 6, 2026.

Revenue and net incomeRevenueNet income
$0$10B$20B$30BQ3'22, Revenue: $22.3BQ3'22, Net income: $1.2BQ3'22Q4'22, Revenue: $15.6BQ4'22, Net income: $1.6BQ4'22Q1'23, Revenue: $15.4BQ1'23, Net income: $80MQ1'23Q2'23, Revenue: $16.6BQ2'23, Net income: $402MQ2'23Q3'23, Revenue: $15.9BQ3'23, Net income: $489MQ3'23Q4'23, Revenue: $19.0BQ4'23, Net income: $607MQ4'23Q1'24, Revenue: $16.1BQ1'24, Net income: $867MQ1'24Q2'24, Revenue: $17.8BQ2'24, Net income: $946MQ2'24Q3'24, Revenue: $18.4BQ3'24, Net income: $1.3BQ3'24Q4'24, Revenue: $18.7BQ4'24, Net income: $1.3BQ4'24Q1'25, Revenue: $18.6BQ1'25, Net income: $945MQ1'25Q2'25, Revenue: $17.3BQ2'25, Net income: $729MQ2'25Q3'25, Revenue: $17.4BQ3'25, Net income: $896MQ3'25Q4'25, Revenue: $23.8BQ4'25, Net income: $809MQ4'25Q1'26, Revenue: $19.1BQ1'26, Net income: $1.2BQ1'26Q2'26, Revenue: $19.2BQ2'26, Net income: $736MQ2'26$0$10B$20B$30BQ3'22, Revenue: $22.3BQ3'22, Net income: $1.2BQ4'22, Revenue: $15.6BQ4'22, Net income: $1.6BQ4'22Q1'23, Revenue: $15.4BQ1'23, Net income: $80MQ2'23, Revenue: $16.6BQ2'23, Net income: $402MQ2'23Q3'23, Revenue: $15.9BQ3'23, Net income: $489MQ4'23, Revenue: $19.0BQ4'23, Net income: $607MQ4'23Q1'24, Revenue: $16.1BQ1'24, Net income: $867MQ2'24, Revenue: $17.8BQ2'24, Net income: $946MQ2'24Q3'24, Revenue: $18.4BQ3'24, Net income: $1.3BQ4'24, Revenue: $18.7BQ4'24, Net income: $1.3BQ4'24Q1'25, Revenue: $18.6BQ1'25, Net income: $945MQ2'25, Revenue: $17.3BQ2'25, Net income: $729MQ2'25Q3'25, Revenue: $17.4BQ3'25, Net income: $896MQ4'25, Revenue: $23.8BQ4'25, Net income: $809MQ4'25Q1'26, Revenue: $19.1BQ1'26, Net income: $1.2BQ2'26, Revenue: $19.2BQ2'26, Net income: $736MQ2'26

Net income losses drawn in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$10B$20B$30BQ3'22, Cash and equivalents: $22.2BQ3'22Q4'22, Cash and equivalents: $20.2BQ4'22Q1'23, Cash and equivalents: $18.5BQ1'23Q2'23, Cash and equivalents: $15.4BQ2'23Q3'23, Cash and equivalents: $14.9BQ3'23Q4'23, Cash and equivalents: $20.6BQ4'23Q1'24, Cash and equivalents: $19.8BQ1'24Q2'24, Cash and equivalents: $20.8BQ2'24Q3'24, Cash and equivalents: $21.8BQ3'24Q4'24, Cash and equivalents: $20.1BQ4'24Q1'25, Cash and equivalents: $21.3BQ1'25Q2'25, Cash and equivalents: $22.2BQ2'25Q3'25, Cash and equivalents: $20.2BQ3'25Q4'25, Cash and equivalents: $22.0BQ4'25Q1'26, Cash and equivalents: $22.7BQ1'26Q2'26, Cash and equivalents: $19.3BQ2'26$0$10B$20B$30BQ3'22, Cash and equivalents: $22.2BQ4'22, Cash and equivalents: $20.2BQ4'22Q1'23, Cash and equivalents: $18.5BQ2'23, Cash and equivalents: $15.4BQ2'23Q3'23, Cash and equivalents: $14.9BQ4'23, Cash and equivalents: $20.6BQ4'23Q1'24, Cash and equivalents: $19.8BQ2'24, Cash and equivalents: $20.8BQ2'24Q3'24, Cash and equivalents: $21.8BQ4'24, Cash and equivalents: $20.1BQ4'24Q1'25, Cash and equivalents: $21.3BQ2'25, Cash and equivalents: $22.2BQ2'25Q3'25, Cash and equivalents: $20.2BQ4'25, Cash and equivalents: $22.0BQ4'25Q1'26, Cash and equivalents: $22.7BQ2'26, Cash and equivalents: $19.3BQ2'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q2 FY2026 filed August 6, 2026.

MetLife, Inc. income statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 6, 2026Q1 FY2026ended Mar 31, 2026filed May 7, 2026Q4 FY2025ended Dec 31, 2025filed Feb 19, 2026Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025Q2 FY2025ended Jun 30, 2025filed Aug 7, 2025Q1 FY2025ended Mar 31, 2025filed May 1, 2025Q4 FY2024ended Dec 31, 2024filed Feb 21, 2025Q3 FY2024ended Sep 30, 2024filed Nov 1, 2024YoYQ2 FY2026vs Q2 FY2025
Revenue19,15419,07423,81417,36117,34018,56918,66618,440+10.5%
Cost of revenue—————————
Gross profit—————————
Research and development—————————
Selling, general and administrative15413218611813012618162+18.5%
Operating income1,6041,6311,6791,6501,3931,4151,4911,442+15.1%
Other income (expense)—————————
Pretax income1,0351,5071,1171,2109801,3541,3811,994+5.6%
Income tax256345301308245404106653+4.5%
Net income7361,1858098967299451,2711,342+1.0%
Diluted EPS ($)1.091.74—1.221.031.28—1.81+5.8%
Diluted shares (millions)647656—669675687—704—

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q2 FY2026 filed August 6, 2026.

MetLife, Inc. balance sheet, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 6, 2026Q1 FY2026ended Mar 31, 2026filed May 7, 2026Q4 FY2025ended Dec 31, 2025filed Feb 19, 2026Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025Q2 FY2025ended Jun 30, 2025filed Aug 7, 2025Q1 FY2025ended Mar 31, 2025filed May 1, 2025Q4 FY2024ended Dec 31, 2024filed Feb 21, 2025Q3 FY2024ended Sep 30, 2024filed Nov 1, 2024YoYQ2 FY2026vs Q2 FY2025
Cash and equivalents19,30122,68722,03220,23322,17821,32620,06821,765−13.0%
Short-term investments8,0164,9483,6015,9625,3005,5435,1564,609+51.2%
Total current assets—————————
Total assets759,372743,211745,166719,726702,470688,316677,457704,976+8.1%
Total current liabilities—————————
Long-term debt—————————
Total liabilities731,411715,410716,245690,535674,543660,561649,754673,812+8.4%
Stockholders’ equity27,44127,32428,39828,94427,68527,49327,44530,885−0.9%
Shares outstanding (millions)635643652659665671681692—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q2 FY2026 filed August 6, 2026.

MetLife, Inc. cash flow statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 6, 2026Q1 FY2026ended Mar 31, 2026filed May 7, 2026Q4 FY2025ended Dec 31, 2025filed Feb 19, 2026Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025Q2 FY2025ended Jun 30, 2025filed Aug 7, 2025Q1 FY2025ended Mar 31, 2025filed May 1, 2025Q4 FY2024ended Dec 31, 2024filed Feb 21, 2025Q3 FY2024ended Sep 30, 2024filed Nov 1, 2024YoYQ2 FY2026vs Q2 FY2025
Operating cash flow2,2282,6877,0763,5672,1874,2624,6114,169+1.9%
Capital expenditures—————————
Free cash flow (CFO − capex)—————————
Depreciation and amortization—————————
Share repurchases7227554605025101,411406774+41.6%
Dividends paid383372375378382374378383+0.3%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 19, 2026.

Income statement

MetLife, Inc. income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 19, 2026FY2024ended Dec 31, 2024filed Feb 21, 2025FY2023ended Dec 31, 2023filed Feb 16, 2024FY2022ended Dec 31, 2022filed Feb 23, 2023FY2021ended Dec 31, 2021filed Feb 18, 2022FY2020ended Dec 31, 2020filed Feb 19, 2021FY2019ended Dec 31, 2019filed Feb 21, 2020FY2018ended Dec 31, 2018filed Feb 22, 2019FY2017ended Dec 31, 2017filed Mar 1, 2018FY2016ended Dec 31, 2016filed Mar 1, 2017FY2015ended Dec 31, 2015filed Feb 25, 2016FY2014ended Dec 31, 2014filed Feb 27, 2015FY2013ended Dec 31, 2013filed Feb 27, 2014FY2012ended Dec 31, 2012filed Feb 27, 2013FY2011ended Dec 31, 2011filed Feb 28, 2012FY2010ended Dec 31, 2010filed Feb 25, 2011FY2009ended Dec 31, 2009filed Feb 26, 2010FY2008ended Dec 31, 2008filed Aug 4, 2009FY2007ended Dec 31, 2007filed Aug 4, 2009
Revenue77,08470,98666,90568,77068,69667,84269,62067,94162,30860,78761,34373,31668,19968,15070,24152,24740,65750,98247,152
Cost of revenue———————————————————
Gross profit———————————————————
Research and development———————————————————
Selling, general and administrative5604818286696707619019101,1291,0071,417————————
Operating income6,1375,9965,7235,978———————————————
Other income (expense)———————————————————
Pretax income4,6615,6222,1626,3648,5186,9276,7956,3073,5364,2815,6518,8044,0521,4429,1843,729(4,361)——
Income tax1,2581,1785601,0621,6421,5098861,179(1,470)6931,5902,4656611282,7931,110(2,025)1,5801,675
Net income3,3794,4261,5785,2846,8555,4075,8995,1234,0108505,3736,3093,3681,3246,4232,667(2,246)3,2094,317
Diluted EPS ($)4.715.941.816.307.655.686.064.913.620.674.625.422.911.125.762.86(2.89)4.145.48
Diluted shares (millions)6737117628098699139441,0141,0791,1091,1281,1431,1161,0771,068890818745—

Balance sheet

MetLife, Inc. balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 19, 2026FY2024ended Dec 31, 2024filed Feb 21, 2025FY2023ended Dec 31, 2023filed Feb 16, 2024FY2022ended Dec 31, 2022filed Feb 23, 2023FY2021ended Dec 31, 2021filed Feb 18, 2022FY2020ended Dec 31, 2020filed Feb 19, 2021FY2019ended Dec 31, 2019filed Feb 21, 2020FY2018ended Dec 31, 2018filed Feb 22, 2019FY2017ended Dec 31, 2017filed Mar 1, 2018FY2016ended Dec 31, 2016filed Mar 1, 2017FY2015ended Dec 31, 2015filed Feb 25, 2016FY2014ended Dec 31, 2014filed Feb 27, 2015FY2013ended Dec 31, 2013filed Feb 27, 2014FY2012ended Dec 31, 2012filed Feb 27, 2013FY2011ended Dec 31, 2011filed Feb 28, 2012FY2010ended Dec 31, 2010filed Feb 25, 2011FY2009ended Dec 31, 2009filed Feb 26, 2010FY2008ended Dec 31, 2008filed Aug 4, 2009FY2007ended Dec 31, 2007filed Aug 4, 2009
Cash and equivalents22,03220,06820,63920,19520,04719,79516,59815,82112,70112,65111,1829,2057,58515,73810,46112,95710,02424,1319,961
Short-term investments3,6015,1566,0454,9357,1763,9043,8503,9374,8706,5239,2998,62113,95516,90617,3109,3848,37413,878—
Total current assets———————————————————
Total assets745,166677,457687,584663,072759,708795,146740,463687,538719,892898,764877,933902,337885,296836,781796,226730,906539,314501,678—
Total current liabilities———————————————————
Long-term debt——————————————23,69227,58613,2209,667—
Total liabilities716,245649,754657,331632,947691,959720,329674,081634,580661,022831,062809,437829,678822,313771,823738,232681,793505,816477,693—
Stockholders’ equity28,39827,44530,01529,88167,48274,55866,14452,74158,67667,53168,09872,20861,55364,45357,51948,62533,12123,734—
Shares outstanding (millions)6526817237748258849169571,0371,0871,0971,1171,1241,0941,060987819——

Cash flow statement

MetLife, Inc. cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 19, 2026FY2024ended Dec 31, 2024filed Feb 21, 2025FY2023ended Dec 31, 2023filed Feb 16, 2024FY2022ended Dec 31, 2022filed Feb 23, 2023FY2021ended Dec 31, 2021filed Feb 18, 2022FY2020ended Dec 31, 2020filed Feb 19, 2021FY2019ended Dec 31, 2019filed Feb 21, 2020FY2018ended Dec 31, 2018filed Feb 22, 2019FY2017ended Dec 31, 2017filed Mar 1, 2018FY2016ended Dec 31, 2016filed Mar 1, 2017FY2015ended Dec 31, 2015filed Feb 25, 2016FY2014ended Dec 31, 2014filed Feb 27, 2015FY2013ended Dec 31, 2013filed Feb 27, 2014FY2012ended Dec 31, 2012filed Feb 27, 2013FY2011ended Dec 31, 2011filed Feb 28, 2012FY2010ended Dec 31, 2010filed Feb 25, 2011FY2009ended Dec 31, 2009filed Feb 26, 2010FY2008ended Dec 31, 2008filed Aug 4, 2009FY2007ended Dec 31, 2007filed Aug 4, 2009
Operating cash flow17,09214,59813,72113,04412,34711,63913,78611,73812,28314,77414,05216,37616,13117,16010,2737,9853,80310,7029,902
Capital expenditures———————————————————
Free cash flow (CFO − capex)———————————————————
Depreciation and amortization———————————————————
Share repurchases2,8833,2073,1033,3264,3031,1512,2853,9922,9273721,9301,00000—001,2501,705
Dividends paid1,5091,5271,5661,5981,6471,6571,6431,6781,7171,7361,6531,4991,119811787784610592541

Insider activity

Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$0
0 sales by 0 insiders; officers and directors $0
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$2M
1 sales by 1 insider; officers and directors $2M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 1, 2026Johnson Jeh C.Directoraward544$94.35$51K10,101Oct 5, 2026
Oct 1, 2026Hubbard Robert GlennDirectoraward941$94.35$89K109,132Oct 5, 2026
Oct 1, 2026Mumenthaler Christian StephaneDirectoraward544$94.35$51K4,018Oct 5, 2026
Oct 1, 2026Harris Carla ADirectoraward544$94.35$51K11,701Oct 5, 2026
Oct 1, 2026Weinberger Mark ADirectoraward544$0.00—19,932Oct 5, 2026
Oct 1, 2026Mckenzie DianaDirectoraward544$94.35$51K25,929Oct 5, 2026
Oct 1, 2026Seitz MichelleDirectoraward544$0.00—2,125Oct 5, 2026
Oct 1, 2026Hay Laura JDirectoraward544$94.35$51K6,901Oct 5, 2026
Oct 1, 2026Glaser Daniel SDirectoraward544$94.35$51K3,249Oct 5, 2026
Oct 1, 2026Kennard William EDirectoraward544$94.35$51K48,248Oct 5, 2026
Sep 8, 2026Tadros RamyPresident, U.S. Businessaward115$95.50$11K212,695Sep 10, 2026
Sep 8, 2026Kennard William EDirectoraward294$95.50$28K47,704Sep 10, 2026
Sep 8, 2026Mumenthaler Christian StephaneDirectoraward21$95.50$2K3,474Sep 10, 2026
Sep 8, 2026Hay Laura JDirectoraward39$95.50$4K6,357Sep 10, 2026
Sep 8, 2026Harris Carla ADirectoraward42$95.50$4K11,157Sep 10, 2026
Sep 8, 2026Hubbard Robert GlennDirectoraward618$95.50$59K108,191Sep 10, 2026
Sep 8, 2026Johnson Jeh C.Directoraward59$95.50$6K9,557Sep 10, 2026
Sep 8, 2026Mckenzie DianaDirectoraward157$95.50$15K25,385Sep 10, 2026
Sep 8, 2026Glaser Daniel SDirectoraward10$95.50$9552,705Sep 10, 2026
Aug 31, 2026Pappas BillEVP, Global Tech. & Ops.tax withholding4,030$95.17$384K79,716Sep 2, 2026
Aug 31, 2026McCallion John D.EVP & Chief Financial Officertax withholding6,057$95.17$576K269,137Sep 2, 2026
Aug 31, 2026Debel MarleneEVP & Chief Risk Officertax withholding4,030$95.17$384K150,350Sep 2, 2026
Aug 31, 2026Tadros RamyPresident, U.S. Businesstax withholding4,366$95.17$416K212,580Sep 2, 2026
Jun 16, 2026Mumenthaler Christian StephaneDirectoraward587$87.40$51K3,452Jun 18, 2026
Jun 16, 2026Kennard William EDirectoraward587$87.40$51K47,410Jun 18, 2026

Full insider history for MetLife, Inc., or insider activity across all companies. A record of filings, not a recommendation.

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
MetLife, Inc., CIK 1099219 on EDGAR
Extract generated
October 6, 2026
Withheld
3 line-years whose four quarters do not sum to the filed year: revenue FY2015, income tax FY2016, pretax income FY2016
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: Revenues
Cost of revenue: not filed
Gross profit: not filed
Research and development: not filed
Selling, general and administrative: GeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): not filed
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: ShortTermInvestments
Total current assets: not filed
Total assets: Assets
Total current liabilities: not filed
Long-term debt: LongTermDebt
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: not filed
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationAmortizationAndAccretionNet
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated October 6, 2026.

JSON file
/data/financials/MET.json